檢索結果 - Nicholas C. Turner

Refine Results
  1. 1
    Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?

    Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence? 由 Nicholas C. Turner, Andrew Tutt

    出版 2012
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  2. 2
    Targeting the PI3-kinase pathway in triple-negative breast cancer

    Targeting the PI3-kinase pathway in triple-negative breast cancer 由 Javier Pascual, Nicholas C. Turner

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Managing a Long and Winding Road: Estrogen Receptor–Positive Breast Cancer

    Managing a Long and Winding Road: Estrogen Receptor–Positive Breast Cancer 由 Michael Gnant, Nicholas C. Turner, Cristina Hernándo

    出版 2023
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Molecular Residual Disease and Adjuvant Trial Design in Solid Tumors

    Molecular Residual Disease and Adjuvant Trial Design in Solid Tumors 由 Maria Coakley, Isaac García-Murillas, Nicholas C. Turner

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

    Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer 由 Nicholas C. Turner, Cynthia Huang Bartlett, Massimo Cristofanilli

    出版 2015
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  6. 6
    The history and future of targeting cyclin-dependent kinases in cancer therapy

    The history and future of targeting cyclin-dependent kinases in cancer therapy 由 Uzma Asghar, Agnieszka K. Witkiewicz, Nicholas C. Turner, Erik S. Knudsen

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    CDK4/6 Inhibitors: Promising Opportunities beyond Breast Cancer

    CDK4/6 Inhibitors: Promising Opportunities beyond Breast Cancer 由 Joline S.J. Lim, Nicholas C. Turner, Timothy A. Yap

    出版 2016
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  8. 8
    Parallel RNA Interference Screens Identify EGFR Activation as an Escape Mechanism in <i>FGFR3</i>-Mutant Cancer

    Parallel RNA Interference Screens Identify EGFR Activation as an Escape Mechanism in <i>FGFR3</i>-Mutant Cancer 由 María Teresa Herrera-Abreu, Alex Pearson, James Campbell, Steven D. Shnyder, Margaret A. Knowles, Alan Ashworth, Nicholas C. Turner

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

    A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor 由 Nicholas C. Turner, Christopher J. Lord, Elizabeth Iorns, Rachel Brough, Sally Swift, Richard Elliott, Sydonia Rayter, Andrew Tutt, Alan Ashworth

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways

    Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways 由 Marieke Aarts, Ilirjana Bajrami, María Teresa Herrera-Abreu, Richard Elliott, Rachel Brough, Alan Ashworth, Christopher J. Lord, Nicholas C. Turner

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1

    Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1 由 Marieke Aarts, Rachel Sharpe, Isaac García-Murillas, Heidrun Gevensleben, Melissa S. Hurd, Stuart D. Shumway, Carlo Toniatti, Alan Ashworth, Nicholas C. Turner

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR

    Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR 由 Heidrun Gevensleben, Isaac García-Murillas, Monika Graeser, Gaia Schiavon, Peter Osin, Marina Parton, Ian E. Smith, Alan Ashworth, Nicholas C. Turner

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

    Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer 由 Elizabeth Iorns, Nicholas C. Turner, Richard Elliott, Nelofer Syed, Ornella Garrone, Milena Gasco, Andrew Tutt, Tim Crook, Christopher J. Lord, Alan Ashworth

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer

    Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer 由 Sarah Barton, Lila Zabaglo, Roger A’Hern, Nicholas C. Turner, Thomas Ferguson, Suzanne C. O’Neill, Margaret Hills, Ian Smith, Mitch Dowsett

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype

    Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype 由 Amanda Fitzpatrick, Marjan Iravani, Adam Mills, David Vicente, Thanussuyah Alaguthurai, Ioannis Roxanis, Nicholas C. Turner, Syed Haider, Andrew Tutt, Clare M. Isacke

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysis

    FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysis 由 Somaia Elsheikh, Andrew R. Green, Maryou B. Lambros, Nicholas C. Turner, Matthew J. Grainge, Des G. Powe, Ian O. Ellis, Jorge S. Reis‐Filho

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Exploiting the DNA Repair Defect in BRCA Mutant Cells in the Design of New Therapeutic Strategies for Cancer

    Exploiting the DNA Repair Defect in BRCA Mutant Cells in the Design of New Therapeutic Strategies for Cancer 由 Andrew Tutt, Christopher J. Lord, Nuala McCabe, Hannah Farmer, Nicholas C. Turner, Niall M.B. Martin, Stephen P. Jackson, Graeme C.M. Smith, Alan Ashworth

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both <i>In Vitro</i> and <i>In Vivo</i>

    FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both <i>In Vitro</i> and <i>In Vivo</i> 由 Rachel Sharpe, Alex Pearson, María Teresa Herrera-Abreu, Damian Johnson, Alan Mackay, Jonathan Welti, Rachael Natrajan, Andrew R. Reynolds, Jorge S. Reis‐Filho, Alan Ashworth, Nicholas C. Turner

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial

    Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA... 由 Nadia Harbeck, Shrividya Iyer, Nicholas C. Turner, Massimo Cristofanilli, Jungsil Ro, Fabrice André, Sherene Loi, S. Verma, Hiroji Iwata, Helen Bhattacharyya, Kathy Puyana Theall, Cynthia Huang Bartlett, Sibylle Loibl

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer

    Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer 由 Charlotte Fribbens, Isaac García-Murillas, Matthew Beaney, Sarah Hrebien, Ben O’Leary, Lucy Kilburn, Karen Howarth, Michael Epstein, E. Green, Nitzan Rosenfeld, Alistair Ring, S. Johnston, Nicholas C. Turner

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: